Search research articles
Contact Us
Filters
Showing results (41-50 of 81) with videos related to
Page
of 9
Sort By:
Alzheimer'S Research & Therapy
|
May 14, 2026
Clinical correlates of sleep profiles in dementia with Lewy bodies: a latent class approach
Léa Renard, Clément Aveneau, Karl Götze, et al.
International Journal of Bipolar Disorders
|
December 31, 2024
Brain 18FDG-PET pattern in cognitively impaired elderly patients with bipolar disorder
Nouredine Saleh, Capucine Blaise, Amina Daoudi, et al.
Alzheimer'S Research & Therapy
|
May 23, 2022
Plasma neuregulin 1 as a synaptic biomarker in Alzheimer's disease: a discovery cohort study
Agathe Vrillon, François Mouton-Liger, Matthieu Martinet, et al.
International Journal of Molecular Sciences
|
November 11, 2022
Cerebrospinal Fluid Alpha-Synuclein Improves the Differentiation between Dementia with Lewy Bodies and Alzheimer's Disease in Clinical Practice
Matthieu Lilamand, Josué Clery, Agathe Vrillon, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
February 4, 2015
Potassium channelopathy-like defect underlies early-stage cerebrovascular dysfunction in a genetic model of small vessel disease
Fabrice Dabertrand, Christel Krøigaard, Adrian D Bonev, et al.
Alcoholism, Clinical and Experimental Research
|
January 24, 2021
Cerebrospinal Fluid Biomarkers in Patients With Alcohol Use Disorder and Persistent Cognitive Impairment
Julien Azuar, Elodie Bouaziz-Amar, Emmanuel Cognat, et al.
Clinical Chemistry and Laboratory Medicine
|
August 30, 2025
Cerebrospinal fluid leptin in Alzheimer's disease: relationship to plasma levels and to cerebrospinal amyloid
Elodie Bouaziz-Amar, Jeanne Neez, Fidaa Ibrahim, et al.
Alzheimer'S Research & Therapy
|
March 30, 2019
CSF level of β-amyloid peptide predicts mortality in Alzheimer's disease
Adla Boumenir, Emmanuel Cognat, Severine Sabia, et al.
Journal of Alzheimer'S Disease : JAD
|
October 22, 2025
Cerebrospinal fluid acetylcholine is not a reliable diagnostic marker for Alzheimer's disease and dementia with Lewy bodies
Clément Aveneau, Elodie Lamy, Stanislas Grassin-Delyle, et al.
Journal of Neurology
|
March 24, 2026
Eligibility for lecanemab treatment in a French memory clinic setting
Agathe Vrillon, Karl Götze, Julien Dumurgier, et al.
Page
of 9
Search research articles
Search
Showing results (41-50 of 81) with videos related to
Sort By:
Page
of 9
Alzheimer'S Research & Therapy
|
May 14, 2026
Clinical correlates of sleep profiles in dementia with Lewy bodies: a latent class approach
Léa Renard, Clément Aveneau, Karl Götze, et al.
International Journal of Bipolar Disorders
|
December 31, 2024
Brain 18FDG-PET pattern in cognitively impaired elderly patients with bipolar disorder
Nouredine Saleh, Capucine Blaise, Amina Daoudi, et al.
Alzheimer'S Research & Therapy
|
May 23, 2022
Plasma neuregulin 1 as a synaptic biomarker in Alzheimer's disease: a discovery cohort study
Agathe Vrillon, François Mouton-Liger, Matthieu Martinet, et al.
International Journal of Molecular Sciences
|
November 11, 2022
Cerebrospinal Fluid Alpha-Synuclein Improves the Differentiation between Dementia with Lewy Bodies and Alzheimer's Disease in Clinical Practice
Matthieu Lilamand, Josué Clery, Agathe Vrillon, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
February 4, 2015
Potassium channelopathy-like defect underlies early-stage cerebrovascular dysfunction in a genetic model of small vessel disease
Fabrice Dabertrand, Christel Krøigaard, Adrian D Bonev, et al.
Alcoholism, Clinical and Experimental Research
|
January 24, 2021
Cerebrospinal Fluid Biomarkers in Patients With Alcohol Use Disorder and Persistent Cognitive Impairment
Julien Azuar, Elodie Bouaziz-Amar, Emmanuel Cognat, et al.
Clinical Chemistry and Laboratory Medicine
|
August 30, 2025
Cerebrospinal fluid leptin in Alzheimer's disease: relationship to plasma levels and to cerebrospinal amyloid
Elodie Bouaziz-Amar, Jeanne Neez, Fidaa Ibrahim, et al.
Alzheimer'S Research & Therapy
|
March 30, 2019
CSF level of β-amyloid peptide predicts mortality in Alzheimer's disease
Adla Boumenir, Emmanuel Cognat, Severine Sabia, et al.
Journal of Alzheimer'S Disease : JAD
|
October 22, 2025
Cerebrospinal fluid acetylcholine is not a reliable diagnostic marker for Alzheimer's disease and dementia with Lewy bodies
Clément Aveneau, Elodie Lamy, Stanislas Grassin-Delyle, et al.
Journal of Neurology
|
March 24, 2026
Eligibility for lecanemab treatment in a French memory clinic setting
Agathe Vrillon, Karl Götze, Julien Dumurgier, et al.
Page
of 9